Versartis, Inc. (VSAR) - NASDAQ
From other sites
Company Description
Versartis, Inc. is an endocrine-focused biopharmaceutical company. It develops long-acting therapeutic proteins for the treatment of endocrine disorders. The company develops new therapeutic proteins utilizing the novel half-life extension technology XTEN. Versartis was founded by Jeffrey L.... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States